It is known that TUDCA reduces the accumulation of βA plaques in transgenic APP/PS1 AD mice model, in addition to decreasing the activation of astrocytes and microglia, which results in attenuation of neurotoxic potential and inflammatory response, as well as in decreased loss of neuronal integrity, altogether resulting in improved cognitive ability21–23. This evidence concerns the gene APP and Alzheimer disease.